{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:18:14Z","timestamp":1785295094897,"version":"3.55.0"},"reference-count":67,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","award":["IIT-2021-024"],"award-info":[{"award-number":["IIT-2021-024"]}],"id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cl\u00ednica Colman"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Real-world evidence on the use of vortioxetine within cardiac rehabilitation (CR) programs among patients with major depressive disorder (MDD) remains limited. We aimed to describe the evolution of depressive symptoms, functional status, and selected cardiovascular and biometric parameters in patients with MDD undergoing CR while receiving vortioxetine in routine clinical practice. Methods: This was a 12-week, prospective, observational study conducted at Cl\u00ednica Colman (C\u00e1diz, Spain) between July 2022 and July 2024. Adults diagnosed with MDD who were undergoing CR and receiving vortioxetine as part of routine care were included. Depressive symptoms (Hamilton Depression Rating Scale, HAM-D) and functional impairment (Sheehan Disability Scale, SDS) were assessed at baseline and at weeks 3, 7, and 12. Cardiovascular and biometric parameters were measured at baseline and at week 12. Repeated-measures ANOVA and paired t-tests were used for statistical analysis. Results: Forty-nine patients were included (mean age 65.6 years; 41% women). Over the 12-week follow-up period, mean HAM-D and SDS scores decreased over time (both p &lt; 0.001). Changes were also observed in VO2 max, body weight, body mass index, and waist circumference (all p &lt; 0.05). Left ventricular ejection fraction, blood pressure, and QTc interval showed no relevant variation during follow-up. Mild adverse effects were reported in 6.1% of patients. Conclusions: In patients with MDD and undergoing CR while receiving vortioxetine, longitudinal changes were observed in psychological, functional, and selected cardiovascular measures. These real-world data describe clinical trajectories within integrated rehabilitation settings and provide hypothesis-generating evidence for future controlled studies.<\/jats:p>","DOI":"10.3390\/jcm15041374","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:16:38Z","timestamp":1770722198000},"page":"1374","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Depressive Symptoms, Functional Status, and Cardiovascular Parameters in Patients with Major Depressive Disorder Undergoing Cardiac Rehabilitation While Treated with Vortioxetine: A Prospective Observational Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1033-9548","authenticated-orcid":false,"given":"Iv\u00e1n Hoditx","family":"Mart\u00edn-Costa","sequence":"first","affiliation":[{"name":"Cl\u00ednica Colman Especialidades M\u00e9dicas, 11008 C\u00e1diz, Spain"},{"name":"MOVE-IT Research Group, Department of Physical Education, Faculty of Education Sciences, Instituto de Investigaci\u00f3n e Innovaci\u00f3n Biom\u00e9dica de C\u00e1diz (INiBICA), Universidad de C\u00e1diz, 11519 C\u00e1diz, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Colman","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Colman Especialidades M\u00e9dicas, 11008 C\u00e1diz, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Garc\u00eda-Amador","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Colman Especialidades M\u00e9dicas, 11008 C\u00e1diz, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Garc\u00eda-Caballero","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Colman Especialidades M\u00e9dicas, 11008 C\u00e1diz, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer\u00f3nimo","family":"Acosta-Rueda","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Colman Especialidades M\u00e9dicas, 11008 C\u00e1diz, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Font\u00e1n-Esteban","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Colman Especialidades M\u00e9dicas, 11008 C\u00e1diz, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yerika","family":"Mart\u00edn-Quero","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Colman Especialidades M\u00e9dicas, 11008 C\u00e1diz, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/spcare-2022-003884","article-title":"Depression Prevalence in Cardiovascular Disease: Global Systematic Review and Meta-Analysis","volume":"13","author":"Rafiei","year":"2023","journal-title":"BMJ Support. Palliat. Care"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1093\/eurheartj\/ehaf191","article-title":"2025 ESC Clinical Consensus Statement on Mental Health and Cardiovascular Disease: Developed under the Auspices of the ESC Clinical Practice Guidelines Committee","volume":"46","author":"Bueno","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1192\/bjp.bp.112.111195","article-title":"Adjusted Prognostic Association of Depression Following Myocardial Infarction with Mortality and Cardiovascular Events: Individual Patient Data Meta-Analysis","volume":"203","author":"Meijer","year":"2013","journal-title":"Br. J. Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1161\/CIR.0000000000000019","article-title":"Depression as a Risk Factor for Poor Prognosis among Patients with Acute Coronary Syndrome: Systematic Review and Recommendations: A Scientific Statement from the American Heart Association","volume":"129","author":"Lichtman","year":"2014","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijcard.2016.06.068","article-title":"Depression as an Independent Prognostic Factor for All-Cause Mortality after a Hospital Admission for Worsening Heart Failure","volume":"220","author":"Sokoreli","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12160-016-9777-9","article-title":"Direction of Association between Depressive Symptoms and Lifestyle Behaviors in Patients with Coronary Heart Disease: The Heart and Soul Study","volume":"50","author":"Sin","year":"2016","journal-title":"Ann. Behav. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/1054773813481801","article-title":"The Role of Depression in Medication Adherence among Heart Failure Patients","volume":"23","author":"Tang","year":"2014","journal-title":"Clin. Nurs. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e2246317","DOI":"10.1001\/jamanetworkopen.2022.46317","article-title":"Assessment of Depression and Adherence to Guideline-Directed Medical Therapies Following Percutaneous Coronary Intervention","volume":"5","author":"Lapa","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s11886-022-01815-0","article-title":"The Role of Depression on Treatment Adherence in Patients with Heart Failure-a Systematic Review of the Literature","volume":"24","author":"Poletti","year":"2022","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1525-1497.2006.00586.x","article-title":"Persistent Depression Affects Adherence to Secondary Prevention Behaviors after Acute Coronary Syndromes","volume":"21","author":"Kronish","year":"2006","journal-title":"J. Gen. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/10615806.2021.1952191","article-title":"Depression and Anxiety in Cardiac Rehabilitation: Differential Associations with Changes in Exercise Capacity and Quality of Life","volume":"35","author":"Bermudez","year":"2022","journal-title":"Anxiety Stress Coping"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4088\/JCP.09m05810blu","article-title":"Major Depressive Disorder Predicts Completion, Adherence, and Outcomes in Cardiac Rehabilitation: A Prospective Cohort Study of 195 Patients with Coronary Artery Disease","volume":"72","author":"Swardfager","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2006.06.055","article-title":"Depression in Heart Failure. A Meta-Analytic Review of Prevalence, Intervention Effects, and Associations With Clinical Outcomes","volume":"48","author":"Rutledge","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/2047487315571889","article-title":"Depression and Anxiety Symptoms as Predictors of Mortality in PCI Patients at 10 Years of Follow-Up","volume":"23","author":"Utens","year":"2016","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.108.190769","article-title":"Depression and Coronary Heart Disease: Recommendations for Screening, Referral, and Treatment: A Science Advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Psychiatric Association","volume":"118","author":"Lichtman","year":"2008","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the Management of Chronic Coronary Syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the Management of Acute Coronary Syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1517\/14740338.2015.1085970","article-title":"Safety and Tolerability of Antidepressant Co-Treatment in Acute Major Depressive Disorder: Results from a Systematic Review and Exploratory Meta-Analysis","volume":"14","author":"Galling","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s40263-020-00763-z","article-title":"The Cardiovascular Effects of Newer Antidepressants in Older Adults and Those With or At High Risk for Cardiovascular Diseases","volume":"34","author":"Behlke","year":"2020","journal-title":"CNS Drugs"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2850.2004.00751.x","article-title":"Exercise: A Neglected Intervention in Mental Health Care?","volume":"11","author":"Callaghan","year":"2004","journal-title":"J. Psychiatr. Ment. Health Nurs."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/BPL-160040","article-title":"The Effects of Acute Exercise on Mood, Cognition, Neurophysiology, and Neurochemical Pathways: A Review","volume":"2","author":"Basso","year":"2016","journal-title":"Brain Plast."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PSY.0000000000000944","article-title":"Hybrid Systematic Review and Network Meta-Analysis of Randomized Controlled Trials of Interventions for Depressive Symptoms in Patients with Coronary Artery Disease","volume":"83","author":"Doyle","year":"2021","journal-title":"Psychosom. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/2047487320913379","article-title":"Secondary Prevention through Comprehensive Cardiovascular Rehabilitation: From Knowledge to Implementation. 2020 Update. A Position Paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology","volume":"28","author":"Ambrosetti","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_25","first-page":"CD001800","article-title":"Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease","volume":"11","author":"Dibben","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Prasitlumkum, N., Cheungpasitporn, W., Tokavanich, N., Ding, K.R., Kewcharoen, J., Thongprayoon, C., Kaewput, W., Bathini, T., Vallabhajosyula, S., and Chokesuwattanaskul, R. (2021). Antidepressants and Risk of Sudden Cardiac Death: A Network Meta-Analysis and Systematic Review. Med. Sci., 9.","DOI":"10.3390\/medsci9020026"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e1090","DOI":"10.4088\/JCP.16f11128","article-title":"Cardiometabolic Risks in Schizophrenia and Directions for Intervention, 3: Psychopharmacological Interventions","volume":"77","author":"Andrade","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/psyg.12521","article-title":"Evaluation of Frequency of Occurrence of Cognitive Impairment in the Course of Arterial Hypertension in an Elderly Population","volume":"20","author":"Kapusta","year":"2020","journal-title":"Psychogeriatrics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/2047487320924912","article-title":"Secondary Prevention and Rehabilitation Section of EAPC Reviewers. Standardization and Quality Improvement of Secondary Prevention through Cardiovascular Rehabilitation Programmes in Europe: The Avenue towards EAPC Accreditation Programme: A Position Statement of the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology (EAPC)","volume":"28","author":"Abreu","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jacc.2019.01.041","article-title":"Screening and Management of Depression in Patients With Cardiovascular Disease","volume":"73","author":"Jha","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1002\/ehf2.12861","article-title":"Antidepressant Treatment in Patients Following Acute Coronary Syndromes: A Systematic Review and Bayesian Meta-Analysis","volume":"7","author":"Sweda","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_32","first-page":"CD008012","article-title":"Psychological and Pharmacological Interventions for Depression in Patients with Coronary Artery Disease","volume":"12","author":"Tully","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10741-019-09850-w","article-title":"Effect of Antidepressants on Death in Patients with Heart Failure: A Systematic Review and Meta-Analysis","volume":"25","author":"He","year":"2020","journal-title":"Heart Fail. Rev."},{"key":"ref_34","first-page":"2020-5-4","article-title":"The Impact of Antidepressants on Depressive Symptom Severity, Quality of Life, Morbidity, and Mortality in Heart Failure: A Systematic Review","volume":"9","author":"Hedrick","year":"2020","journal-title":"Drugs Context"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000486794","article-title":"Antidepressant Use by Class: Association with Major Adverse Cardiac Events in Patients with Coronary Artery Disease","volume":"87","author":"Grace","year":"2018","journal-title":"Psychother. Psychosom."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1017\/S1461145714000546","article-title":"A Randomized, Double-Blind, Placebo-Controlled Study of Vortioxetine on Cognitive Function in Depressed Adults","volume":"17","author":"McIntyre","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s40263-014-0195-x","article-title":"Vortioxetine: A Review of Its Use in Major Depressive Disorder","volume":"28","year":"2014","journal-title":"CNS Drugs"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jad.2017.11.081","article-title":"Vortioxetine Improves Symptomatic and Functional Outcomes in Major Depressive Disorder: A Novel Dual Outcome Measure in Depressive Disorders","volume":"227","author":"Christensen","year":"2018","journal-title":"J. Affect. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/HCR.0000000000000699","article-title":"Meta-Analysis of Antidepressant Pharmacotherapy in Patients Eligible for Cardiac Rehabilitation: ANTIDEPRESSANT AMBIVALENCE","volume":"42","author":"Hughes","year":"2022","journal-title":"J. Cardiopulm. Rehabil. Prev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1067\/mhj.2002.123580","article-title":"Treatment of Depression after Myocardial Infarction and the Effects on Cardiac Prognosis and Quality of Life: Rationale and Outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT)","volume":"144","author":"Honig","year":"2002","journal-title":"Am. Heart J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.psy.0000133362.75075.a6","article-title":"Depression and Late Mortality after Myocardial Infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) Study","volume":"66","author":"Carney","year":"2004","journal-title":"Psychosom. Med."},{"key":"ref_42","first-page":"382","article-title":"Factors That Predispose Women to Greater Depressive Symptoms: A Sex-, Age-, and Diagnosis-Matched Cardiac Rehabilitation Cohort","volume":"37","author":"Marzolini","year":"2021","journal-title":"Can. J. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"European Society of Cardiology: Cardiovascular Disease Statistics 2019","volume":"41","author":"Timmis","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_44","unstructured":"(2025, March 01). INEbase\/Demograf\u00eda y Poblaci\u00f3n\/Cifras de Poblaci\u00f3n y Censos Demogr\u00e1ficos\/Cifras de Poblaci\u00f3n\/\u00daltimos Datos. Available online: https:\/\/www.ine.es\/dyngs\/INEbase\/es\/operacion.htm?c=Estadistica_C&cid=1254736176951&menu=ultiDatos&idp=1254735572981."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/eurheartj\/eht462","article-title":"Depression and Cardiovascular Disease: A Clinical Review","volume":"35","author":"Hare","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM-5 (R)), American Psychiatric Association Publishing. [5th ed.].","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A Rating Scale for Depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0022-3956(88)90024-6","article-title":"A New Validation of the Hamilton Rating Scale for Depression","volume":"22","year":"1988","journal-title":"J. Psychiatr. Res."},{"key":"ref_49","unstructured":"Sheehan, D.V. (1983). The Sheehan Disability Scales. The Anxiety Disease, Scribner."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2753.2009.01211.x","article-title":"Factor Structure, Internal Consistency and Construct Validity of the Sheehan Disability Scale in a Spanish Primary Care Sample","volume":"16","author":"Luciano","year":"2010","journal-title":"J. Eval. Clin. Pract."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8323","DOI":"10.1007\/s12035-019-01670-1","article-title":"Physical Exercise and Neuroinflammation in Major Depressive Disorder","volume":"56","author":"Plissari","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Murawska-Cia\u0142owicz, E., Wiatr, M., Cia\u0142owicz, M., Gomes de Assis, G., Borowicz, W., Rocha-Rodrigues, S., Paprocka-Borowicz, M., and Marques, A. (2021). BDNF Impact on Biological Markers of Depression-Role of Physical Exercise and Training. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18147553"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1089\/acm.2019.0234","article-title":"Thalamic Gamma Aminobutyric Acid Level Changes in Major Depressive Disorder after a 12-Week Iyengar Yoga and Coherent Breathing Intervention","volume":"26","author":"Streeter","year":"2020","journal-title":"J. Altern. Complement. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1161\/CIR.0000000000001189","article-title":"Resistance Exercise Training in Individuals with and without Cardiovascular Disease: 2023 Update: A Scientific Statement from the American Heart Association","volume":"149","author":"Paluch","year":"2024","journal-title":"Circulation"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.apnu.2024.10.020","article-title":"Combined Mindfulness-Based Stress Reduction and Physical Activity Improved Psychological Factors and Sleep Quality in Patients with MDD: A Randomized Controlled Trial Study","volume":"53","author":"Norouzi","year":"2024","journal-title":"Arch. Psychiatr. Nurs."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Rezaie, L., Norouzi, E., Bratty, A.J., and Khazaie, H. (2023). Better Sleep Quality and Higher Physical Activity Levels Predict Lower Emotion Dysregulation among Persons with Major Depression Disorder. BMC Psychol., 11.","DOI":"10.1186\/s40359-023-01213-3"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/jpet.111.189068","article-title":"Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder","volume":"340","author":"Pehrson","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/YIC.0b013e3283542457","article-title":"A Randomized, Double-Blind, Placebo-Controlled, Duloxetine-Referenced, Fixed-Dose Study Comparing the Efficacy and Safety of Lu AA21004 in Elderly Patients with Major Depressive Disorder","volume":"27","author":"Katona","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/npp.2015.52","article-title":"A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder","volume":"40","author":"Mahableshwarkar","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.autneu.2013.11.004","article-title":"Depression and Reduced Heart Rate Variability after Cardiac Surgery: The Mediating Role of Emotion Regulation","volume":"180","author":"Patron","year":"2014","journal-title":"Auton. Neurosci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"247","DOI":"10.31083\/j.rcm2409247","article-title":"Depression Following Acute Coronary Syndrome: A Review","volume":"24","author":"Pan","year":"2023","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.euroneuro.2016.03.007","article-title":"A Meta-Analysis of Randomized, Placebo-Controlled Trials of Vortioxetine for the Treatment of Major Depressive Disorder in Adults","volume":"26","author":"Thase","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1503\/jpn.140120","article-title":"Vortioxetine: A Meta-Analysis of 12 Short-Term, Randomized, Placebo-Controlled Clinical Trials for the Treatment of Major Depressive Disorder","volume":"40","author":"Pae","year":"2015","journal-title":"J. Psychiatry Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1001\/jama.289.23.3106","article-title":"Effects of Treating Depression and Low Perceived Social Support on Clinical Events After Myocardial Infarction","volume":"289","author":"Berkman","year":"2003","journal-title":"JAMA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.genhosppsych.2011.02.007","article-title":"Prognostic Association of Depression Following Myocardial Infarction with Mortality and Cardiovascular Events: A Meta-Analysis of 25 Years of Research","volume":"33","author":"Meijer","year":"2011","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PSY.0b013e318291d798","article-title":"A Meta-Analysis of Mental Health Treatments and Cardiac Rehabilitation for Improving Clinical Outcomes and Depression among Patients with Coronary Heart Disease","volume":"75","author":"Rutledge","year":"2013","journal-title":"Psychosom. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1017\/S2045796018000380","article-title":"Medicine-Based Evidence: The Case of Antidepressants in Patients with Coronary Artery Disease","volume":"28","author":"Barbui","year":"2019","journal-title":"Epidemiol. Psychiatr. Sci."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/4\/1374\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:48:11Z","timestamp":1770724091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/4\/1374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":67,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["jcm15041374"],"URL":"https:\/\/doi.org\/10.3390\/jcm15041374","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}